guarantee of returns, and that unit redemption ahead of the target date set in the investment scheme is not allowed must be clearly communicated to investors.In addition, advertisement based on past
management companies must not charge the funds an advertisement fee, except that the advertisement is evenly beneficial to the funds and all unit holders. Also, the companies must not charge the funds for the
performance of the Group Unit: Million Baht 2019 2018 Increase (decrease) Variance (%) Total revenues 6,797 8,080 (1,283) (16%) Net profit 331 526 (195) (37%) The Group’s total revenues for 2019 amounted Baht
operating results with the same period of the prior year, the group’s net profits increased by Baht 7.69 million, or increased 30% due to the following reasons: 6 Months 6 Months (Unit : Million Baht) 2018
performance of the Group Unit: Million Baht Q3’ 2019 Q3’ 2018 Increase (decrease) Variance (%) Total revenues 1,701 1,875 (174) (9%) Net profit 112 137 (25) (18%) The Group’s total revenues for the third
ดูแลการปฏิบัติงาน (“compliance unit”) ซึ่งมีบทบาทในการ ก ากับดูแลเพื่อให้บริษัทปฏิบัติตามกฎหมายได้อย่างถูกต้อง จึงมีส่วนส าคัญในการลดความเสี่ยงในด้าน กฎหมายแก่บริษัท และผู้บริหารของบริษัท ตลอดจนช่วยรักษา
, operates the business of manufacturing and distribution of dialysis and medical equipment, later in February 2018, NCLpurchased some shares from a shareholder, making it the major shareholder with 52.80% of
solution and other medical product manufacturing and trading business. Previously the company held 44% of all shares. Later in February 2018, the company acquired additional shares from one of the
% % 2020 % 2019 % % Revenue from sale 272.47 41.07% 389.02 71.31% -29.96% 600.81 60.91% 795.91 66.61% -24.51% Revenue from manufacturing and service 105.03 15.83% 147.41 27.02% -28.75% 216.52 21.95% 376.15
in quarter 3/2020. Revenue from manufacturing and service of 419.16 million baht as 227.84 million baht decreased or 35.21 percent when compared to the same period of previous year of 647 million